_version_ 1784750525984538624
author Kaminski, Hannah
Gigan, Mickael
Vermorel, Agathe
Charrier, Manon
Guirle, Laura
Jambon, Frederic
Lacapère, Arthur
Ménard, Coline
Moreau, Karine
Neau-Cransac, Martine
Novion, Marine
Pribat, Frederique
Taton, Benjamin
Borde, Sébastien
Burguet, Laure
Martinez, Charlie
Jasiek, Magali
D’Halluin, Pauline
Lafon, Marie-Edith
Merville, Pierre
Couzi, Lionel
author_facet Kaminski, Hannah
Gigan, Mickael
Vermorel, Agathe
Charrier, Manon
Guirle, Laura
Jambon, Frederic
Lacapère, Arthur
Ménard, Coline
Moreau, Karine
Neau-Cransac, Martine
Novion, Marine
Pribat, Frederique
Taton, Benjamin
Borde, Sébastien
Burguet, Laure
Martinez, Charlie
Jasiek, Magali
D’Halluin, Pauline
Lafon, Marie-Edith
Merville, Pierre
Couzi, Lionel
author_sort Kaminski, Hannah
collection PubMed
description
format Online
Article
Text
id pubmed-9297679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92976792022-07-20 COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders Kaminski, Hannah Gigan, Mickael Vermorel, Agathe Charrier, Manon Guirle, Laura Jambon, Frederic Lacapère, Arthur Ménard, Coline Moreau, Karine Neau-Cransac, Martine Novion, Marine Pribat, Frederique Taton, Benjamin Borde, Sébastien Burguet, Laure Martinez, Charlie Jasiek, Magali D’Halluin, Pauline Lafon, Marie-Edith Merville, Pierre Couzi, Lionel Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-10 2022-07-20 /pmc/articles/PMC9297679/ /pubmed/35870641 http://dx.doi.org/10.1016/j.kint.2022.07.008 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Kaminski, Hannah
Gigan, Mickael
Vermorel, Agathe
Charrier, Manon
Guirle, Laura
Jambon, Frederic
Lacapère, Arthur
Ménard, Coline
Moreau, Karine
Neau-Cransac, Martine
Novion, Marine
Pribat, Frederique
Taton, Benjamin
Borde, Sébastien
Burguet, Laure
Martinez, Charlie
Jasiek, Magali
D’Halluin, Pauline
Lafon, Marie-Edith
Merville, Pierre
Couzi, Lionel
COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
title COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
title_full COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
title_fullStr COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
title_full_unstemmed COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
title_short COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
title_sort covid-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297679/
https://www.ncbi.nlm.nih.gov/pubmed/35870641
http://dx.doi.org/10.1016/j.kint.2022.07.008
work_keys_str_mv AT kaminskihannah covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT giganmickael covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT vermorelagathe covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT charriermanon covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT guirlelaura covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT jambonfrederic covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT lacaperearthur covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT menardcoline covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT moreaukarine covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT neaucransacmartine covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT novionmarine covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT pribatfrederique covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT tatonbenjamin covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT bordesebastien covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT burguetlaure covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT martinezcharlie covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT jasiekmagali covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT dhalluinpauline covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT lafonmarieedith covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT mervillepierre covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders
AT couzilionel covid19morbiditydecreaseswithtixagevimabcilgavimabpreexposureprophylaxisinkidneytransplantrecipientnonrespondersorlowvaccineresponders